ASCENTAGE PHARMA GROUP INTERNATIONAL — All Filings
96 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
3
3/A
424B4
6-K
6-K/A
8-A12B
CERT
CORRESP
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
S-8
S-8 POS
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-063825 | Jul 15, 2025 | Jul 14, 2025 |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-062777 | Jul 10, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-061910 | Jul 8, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-059020 | Jun 27, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-054482 | Jun 16, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-052785 | Jun 10, 2025 | Jun 9, 2025 |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-050238 | Jun 3, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-047081 | May 23, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-045646 | May 20, 2025 | May 19, 2025 |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-036182 | Apr 28, 2025 | — |
| 6-K/A | AMENDMENT NO. 1 TO FORM 6-K | 0001213900-25-034806 | Apr 24, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-033508 | Apr 21, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-032670 | Apr 17, 2025 | Apr 16, 2025 |
| 20-F | ANNUAL REPORT | 0001213900-25-032599 | Apr 16, 2025 | Dec 31, 2024 |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-029928 | Apr 8, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-026253 | Mar 31, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001013762-25-003350 | Mar 27, 2025 | — |
| 6-K/A | AMENDMENT NO. 1 TO FORM 6-K | 0001013762-25-002447 | Mar 26, 2025 | — |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001013762-25-002362 | Mar 26, 2025 | Mar 25, 2025 |
| 6-K | FORM 6-K | 0001171843-25-001431 | Mar 12, 2025 | — |
| 6-K | FORM 6-K | 0001171843-25-001287 | Mar 6, 2025 | Mar 5, 2025 |
| 6-K | FORM 6-K | 0001171843-25-001056 | Feb 25, 2025 | — |
| 6-K | FORM 6-K | 0001171843-25-000840 | Feb 14, 2025 | Feb 13, 2025 |
| 6-K | FORM 6-K | 0001171843-25-000725 | Feb 11, 2025 | Feb 7, 2025 |
| SEC STAFF LETTER | — | 9999999997-25-000222 | Jan 24, 2025 | — |
| 424B4 | 424B4 | 0001104659-25-006029 | Jan 24, 2025 | — |
| S-8 | FORM S-8 | 0001104659-25-005755 | Jan 24, 2025 | — |
| EFFECT | — | 9999999995-25-000168 | Jan 23, 2025 | — |
| CERT | — | 0001354457-25-000039 | Jan 23, 2025 | — |
| 8-A12B | 8-A12B | 0001104659-25-004905 | Jan 21, 2025 | — |
| CORRESP | — | 0001104659-25-004850 | Jan 21, 2025 | — |
| CORRESP | — | 0001104659-25-004849 | Jan 21, 2025 | — |
| F-1/A | F-1/A | 0001104659-25-004650 | Jan 21, 2025 | — |
| F-1 | F-1 | 0001104659-24-132177 | Dec 27, 2024 | — |
| SEC STAFF LETTER | — | 9999999997-24-004636 | Dec 17, 2024 | — |
| DRS/A | — | 0001104659-24-127096 | Dec 10, 2024 | — |
| DRS/A | — | 0001104659-24-099913 | Sep 16, 2024 | — |
| DRSLTR | — | 0001104659-24-099915 | Sep 13, 2024 | — |
| UPLOAD | — | 0000000000-24-010214 | Sep 10, 2024 | — |
| DRSLTR | — | 0001104659-24-093402 | Aug 27, 2024 | — |
| DRS/A | — | 0001104659-24-093399 | Aug 27, 2024 | — |
| UPLOAD | — | 0000000000-24-009387 | Aug 15, 2024 | — |
| DRSLTR | — | 0001104659-24-084111 | Jul 31, 2024 | — |
| DRS/A | — | 0001104659-24-084101 | Jul 31, 2024 | — |
| UPLOAD | — | 0000000000-24-007938 | Jul 12, 2024 | — |
| DRS | — | 0001104659-24-071459 | Jun 14, 2024 | — |